Ann-Jeng Liu

597 total citations
15 papers, 463 citations indexed

About

Ann-Jeng Liu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ann-Jeng Liu has authored 15 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Ann-Jeng Liu's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Autophagy in Disease and Therapy (3 papers). Ann-Jeng Liu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Autophagy in Disease and Therapy (3 papers). Ann-Jeng Liu collaborates with scholars based in Taiwan and United States. Ann-Jeng Liu's co-authors include Ku‐Chung Chen, Chwen-Ming Shih, Kuo-Hao Ho, Peng-Hsu Chen, Chia‐Hsiung Cheng, Cheng‐Wei Lin, Sheng-Huang Hsiao, Sheng-Hao Wang, Wen‐Ta Chiu and Chin-Cheng Lee and has published in prestigious journals such as PLoS ONE, Life Sciences and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Ann-Jeng Liu

15 papers receiving 462 citations

Peers

Ann-Jeng Liu
David Cavazos United States
Fen Pei United States
Kuo-Hao Ho Taiwan
Jiajun Yap Singapore
Ann-Jeng Liu
Citations per year, relative to Ann-Jeng Liu Ann-Jeng Liu (= 1×) peers Peng-Hsu Chen

Countries citing papers authored by Ann-Jeng Liu

Since Specialization
Citations

This map shows the geographic impact of Ann-Jeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann-Jeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann-Jeng Liu more than expected).

Fields of papers citing papers by Ann-Jeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann-Jeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann-Jeng Liu. The network helps show where Ann-Jeng Liu may publish in the future.

Co-authorship network of co-authors of Ann-Jeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ann-Jeng Liu. A scholar is included among the top collaborators of Ann-Jeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann-Jeng Liu. Ann-Jeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ho, Kuo-Hao, Peng-Hsu Chen, Chia‐Hsiung Cheng, et al.. (2024). Hypoxia enhances IL-8 signaling through inhibiting miR-128-3p expression in glioblastomas. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(2). 119885–119885. 1 indexed citations
3.
Ho, Kuo-Hao, et al.. (2021). A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity. Life Sciences. 277. 119438–119438. 18 indexed citations
5.
Ho, Kuo-Hao, Tai-Chih Kuo, Yi‐Ting Lee, et al.. (2020). Xanthohumol regulates miR-4749-5p-inhibited RFC2 signaling in enhancing temozolomide cytotoxicity to glioblastoma. Life Sciences. 254. 117807–117807. 26 indexed citations
6.
Ho, Kuo-Hao, Peng-Hsu Chen, Chwen-Ming Shih, et al.. (2020). miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas. Cellular and Molecular Neurobiology. 42(3). 791–806. 13 indexed citations
7.
Ho, Kuo-Hao, Chia‐Hsiung Cheng, Chih‐Ming Chou, et al.. (2019). miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Pharmacological Research. 147. 104390–104390. 38 indexed citations
8.
Chen, Peng-Hsu, Ann-Jeng Liu, Kuo-Hao Ho, et al.. (2018). microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chemico-Biological Interactions. 291. 144–151. 34 indexed citations
9.
Chen, Peng-Hsu, Kuo-Hao Ho, Chwen-Ming Shih, et al.. (2017). The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA. PLoS ONE. 12(3). e0173890–e0173890. 13 indexed citations
10.
Chen, Peng-Hsu, Chia‐Hsiung Cheng, Chwen‐Ming Shih, et al.. (2016). The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. PLoS ONE. 11(11). e0167096–e0167096. 49 indexed citations
11.
Chen, Peng-Hsu, Cheng-Kuei Chang, Chwen-Ming Shih, et al.. (2016). The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death. Neuropharmacology. 110(Pt A). 362–375. 59 indexed citations
12.
Chen, Peng-Hsu, Chwen‐Ming Shih, Kuo-Hao Ho, et al.. (2016). The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Neuropharmacology. 116. 300–314. 43 indexed citations
13.
14.
Liu, Ann-Jeng, Sheng-Hao Wang, Ku‐Chung Chen, et al.. (2013). Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells. Chemico-Biological Interactions. 205(1). 20–28. 69 indexed citations
15.
Liu, Ann-Jeng, Sheng-Hao Wang, Chien‐Ju Lin, et al.. (2013). Evodiamine Induces Transient Receptor Potential Vanilloid-1-Mediated Protective Autophagy in U87-MG Astrocytes. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026